Perspectives on complement in xenotransplantation.

作者: Tom E Mollnes , Arnt E Fiane

DOI: 10.1016/S0161-5890(03)00106-8

关键词:

摘要: The crucial role of complement and naturally occurring anti-Gal antibodies in hyperacute rejection pig transplants to Old World monkeys, apes humans is well established. This can be prevented by manipulating either system. Although cells, tissues or organs from pigs made transgenic for human regulatory proteins escape rejection, there an increasing evidence a also the subsequent acute vascular delayed xenograft rejection. Furthermore, contributes general manner ischemia-reperfusion injury (IRI), irrespective organ source. Early complement-mediated endothelial cell activation, although not sufficient induce may contribute reduced long-time graft performance. Control fluid-phase activation soluble inhibitors might important adjuvant time harvesting through first post-transplant period. Pharmacologic manipulation field expansion, though still its infancy. optimal cloned close reality, xenotransplantation needs fully elucidated treatment regimen inhibition warranted. story completed but under continuous revision.

参考文章(133)
Homi B. Kapadia, Jeffrey L. Platt, Rathinam S. Selvan, Complement-Induced Expression of Chemokine Genes in Endothelium: Regulation by IL-1-Dependent and -Independent Mechanisms Journal of Immunology. ,vol. 161, pp. 4388- 4395 ,(1998)
D.K.C. Cooper, A.M. Keogh, J. Brink, P.A. Corris, W. Klepetko, R.N. Pierson, M. Schmoeckel, R. Shirakura, L. Warner Stevenson, Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. Journal of Heart and Lung Transplantation. ,vol. 19, pp. 1125- 1165 ,(2000) , 10.1016/S1053-2498(00)00224-2
Jeffrey L. Platt, Xenotransplantation. New risks, new gains. Nature. ,vol. 407, pp. 27- 29 ,(2000) , 10.1038/35024181
M. Kathryn Uszewski, Timothy C. Farries, Douglas M. Lublin, Isabelle A. Rooney, John P. Atkinson, Control of the complement system. Advances in Immunology. ,vol. 61, pp. 201- 283 ,(1996) , 10.1016/S0065-2776(08)60868-8
Z E Holzknecht, W Parker, D Bruno, J L Platt, Characterization and affinity isolation of xenoreactive human natural antibodies. Journal of Immunology. ,vol. 153, pp. 3791- 3803 ,(1994)
Mauro S. Sandrin, Maria Koulmanda, Ian F. C. McKenzie, Tom E. Mandel, Cutting Edge: Pig Islet Xenografts Are Susceptible to “Anti-Pig” But Not Galα(1,3)Gal Antibody Plus Complement in Gal o/o Mice Journal of Immunology. ,vol. 161, pp. 5116- 5119 ,(1998)
C Krischer, H Schelzig, A Vogel, F Simon, D Abendroth, Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor. Annals of Transplantation. ,vol. 6, pp. 34- 39 ,(2001)
Fred Sanfilippo, Fred Sanfilippo, William M. Baldwin, Scott K. Pruitt, Robert B. Brauer, Mohamed R. Daha, Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. Journal of Immunology. ,vol. 151, pp. 7240- 7248 ,(1993)
WILLIAM M. BALDWIN, SCOTT K. PRUITT, ROBERT B. BRAUER, MOHAMED R. DAHA, FRED SANFILIPPO, Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation. ,vol. 59, pp. 797- 808 ,(1995) , 10.1097/00007890-199503000-00001
Guerard W. Byrne, Alexander Schwarz, Joanna R. Fesi, Patrick Birch, Anna Nepomich, Ivona Bakaj, Margaret A. Velardo, Cong Jiang, Adriana Manzi, Howard Dintzis, Lisa E. Diamond, John S. Logan, Evaluation of different α-galactosyl glycoconjugates for use in xenotransplantation Bioconjugate Chemistry. ,vol. 13, pp. 571- 581 ,(2002) , 10.1021/BC015565E